Who We Are
Association of Pharmaceutical Producers of Nepal
APPON (Association of Pharmaceutical Producers of Nepal) was established in the year 1990 A.D by the Pharmaceutical entrepreneurs with the view to facilitate, enhance and improve the service of the Pharmaceutical companies...
70+
Pharmaceutical Producers
45%
National Market Share
Read More
Our Associates
A collaborative effort to deliver excellence in
Nepal’s Pharmaceutical Industry.
Biplab Adhikari
PRESIDENT
PRESIDENT’S
MESSAGE
Dear Friends and Well-Wishers!!
Myself Biplab Adhikari feel privileged to address you as the recently elected President of APPON. I am excited to lead our association through the upcoming transformative phase, fueled by the dedication and enthusiasm of our new executive team.
At present, Nepal boasts eighty active member companies involved in the production of pharmaceuticals of which almost all companies hold National and WHO GMP certifications. Pharmaceutical manufacturing industry with humble beginnings in the 1990s, has evolved into an uprising sector in Nepal with significant potential. Adaptation to evolving healthcare regulations emphasizing good manufacturing practices has propelled Nepali Pharmaceutical Manufacturers forward.
Among the various sustainable sectors poised for economic growth, the Nepali pharmaceutical industry emerges as a particularly dynamic field for investment and advancement in science and technology. Despite Nepal's possession of advanced facilities for pharmaceutical production, there has been a notable decline of 12% in the domestic market share of pharmaceutical consumption in the previous year. If the current trend of favoring unverified foreign products continues to overshadow domestic pharmaceutical industries, Nepal risks being dependent for pharmaceutical needs heavily impacting the overall healthcare sector. To sustain national industries, thereby striving towards the status of a pharmaceutical exporting nation, the support of the Government of Nepal is imperative. Without robust regulatory measures by authorities to ensure the quality of imported goods and policies to control the distribution of unregulated products in the market, the growth of domestic industries will be hindered. A nation's commitment to empowering its industries fosters increased employment opportunities, instills a stronger sense of national identity, fosters higher-quality manufacturing, and ultimately drives economic growth.
Well-being of Nepali people is closely tied to the standards upheld by our pharmaceutical manufacturers. It remains our responsibility to ensure our quality and promotional efforts align with the highest standards, unaffected by unethical influences. Acknowledging the interconnected nature of the pharmaceutical landscape, we invite each APPON member to actively participate, collaborate, and contribute to the realization of our collective vision. APPON is committed to ensuring accessible and affordable high-quality medicines for all Nepali citizens, grounded in ethical manufacturing and marketing practices. Together, we will elevate Nepal's pharmaceutical industry to new heights, not just as a beacon of quality and innovation but as a vital contributor to the nation's health and prosperity
As APPON member companies, we realize our responsibility towards our nation for enhancing access to health and medicines for fellow countrymen. In the past we had bitter experience of restriction imposed on essential critical medicines pushing us to vulnerability. Over dependency on import could lead to limit our health care delivery system. APPON, holds the accountability for uninterrupted supply to every nooks & corners in the country at most affordable price.  
APPON will continue to be defined by excellence, sustainability with positive impact regardless of economic challenges. Thank you for entrusting me the responsibility to lead our esteemed association. Let us forge ahead, hand in hand, towards a dynamic and prosperous future for Nepal's pharmaceutical industry.
Training & Development
We have formed Quality Circle and Marketing Circle as our advisory body.
The two circles were formed with the goal to enhance the quality of Pharmaceuticals during the production as well as marketing practices.
Marketing Circle

Our marketing circle ensures that our fellow companies follow a good marketing practice as we support our companies by involving them in effective marketing discussions for the best sales and distribution outcome throughout Nepal.

Quality Circle

APPON assures that these circles will definitely help for the betterment of Nepalese pharma industries to produce and market quality, safe and effective drugs to serve the nation in a better way.

Key Highlights
70+
Pharmaceutical Companies
50%
WHO-GMP Certified Companies
45%
National Market Share
7+
Pharma Expo conducted
Our Events
Successfully conducting Pharma Exposition since 2005
We conduct our expositions every 2 years since 2005. With this continual effort and dedication, we aim to push the pharma industry of Nepal to be able to compete on a global scale in the near future.
Event Featured Image
March 12, 2026
Nepal Pharma Expo 2026

Strengthening Pharmaceutical Sustenance, Nepal Pharma Expo 2026 is held on Kathmandu, Bhrikutimandap on Falgun 28th to 30th

Continue Reading
Event Featured Image
August 4, 2025
APPON 31th AGm

Association of Pharmaceutical Producers of Nepal (APPON) 31th AGM is held on 19th Shrawan 2082 at Alice Reception, Gairidhara Kathmandu.

Continue Reading
Blogs
Our Articles On Web
 img
औषधीमा आत्मनिर्भरता तर्फ ?

मानव जिवनको सबै भन्दा बढी आवश्यक वस्तु के हो ? भन्ने प्रश्नको जवाफमा सयौं उत्तर आउने गर्छन् । मानवले प्रयोग गर्ने हरेक वस्तु औषधी देखी मोबाइलफोन, खानेकुरा, कपडा, घर सबै आवश्यक छन् । तर यसको जवाफको लागी हामीले मानव जनसंख्याको इतिहाँस हेर्नु पर्ने हुन्छ । इसापुर्व १०,००० वर्ष अगाडी विश्वको जनसंख्या करिब ४ करोड थियो र सन् १७०० मा ०.०४% को बृद्धि दरले ६० करोड, सन् १८०० मा ९९ करोड, सन् १९०० मा १ अर्ब ६५ करोड, सन् २००० मा ६ अर्ब र सन् २०२२ मा ७ अर्ब १९ करोड ३९ लाख ९२ हजार पाँच सय सतह्तर पुग्ने अनुमान छ । करिब ११९०० वर्षमा ४ करोड बाट १ अर्ब ६२ करोड पुगेको जनसंख्या पछिल्लो १२२ वर्षमा ८ अर्ब पुगेको छ । २० औं शताब्दीमा औषधी (एन्टीवायोटीक र भ्याक्सीन) र यूरीया मलको अविस्कार विश्वजनसंख्या बृद्धीको मुख्य कारण हो । औषधी र भ्याकसीनको अविस्कारले एकै झट्कामा करौडौं मान्छे मार्ने रोगहरुबाट र यूरीयामलको प्रयोगले अन्नको बढी उत्पादन भई भोकमारीबाट मानवको मृत्यु रोकेपछी मानव जनसंख्या यो अवस्थामा पुग्न सकेको प्रष्ट छ । यसरी मावन जिवनको अत्यावश्यक बस्तुमा औषधीको महत्व रहेको छ । 


 नेपालमा औषधीको इतिहास 

नेपालमा इसाइ धर्म प्रचारकहरुको प्रवेश सँगै एलोपेथीक औषधीको प्रवेश भएको थियो र वीर अस्पतालको स्थापना पछि यसको प्रयोग बढेको हो । उत्पादनको इतिहाँस हेर्दा २०१८ सालमा पशु रोग निदान प्रयोशालाले गौगोटी ९च्ष्लमभचउभकत० को भ्याक्सीन उत्पादन गरे सँगै औषधी उत्पादनको शुरुवात भएको र २०२७ सालमा पशु तथा मावन प्रयोगको लागी रेवीज भ्याक्सीनको उत्पादन भइ रसायनीक औषधी भन्दा पहिले जैवीक औषधीबाट नेपालमा औषधी उत्पादनको शुरुवात भएको हो । रसायनीक औषधीको हकमा २०२६ सालमा केमीड्रग स्थापना, २०३० सालमा शाही औषधीको स्थापना, २०३५ सालमा औषधी ऐन र २०३६ सालमा औषधी व्यवस्था विभागको स्थापना भए पछि २०४६ सालपछि औषधी उद्योगहरुको विकास भएको हो । २०६१ सालमा पाँचवटा औषधी उद्योगलाई ध्ज्इ न्ःएप्रदान गरि औषधी उत्पादन क्षेत्रमा नयाँ युगको शुरुवात भयो । यसको लागी औषधी व्यवस्था विभागको तत्कालीन महानिर्देशकहरु स्व. डा. अशफाक शेख, स्व. भुपेन्द्र बहादुर थापा र उद्योगीहरुमा स्व. कविराज केशरी, स्व. महेन्द्र बहादुर अमात्य, तिर्थ लाल श्रेष्ठ, स्व. गिरधरलाल मानन्धरको नाम औषधी उत्पादनको इतिहासमा सुनौलो अक्षरले लेखीन्छ । 

 नेपाली औषधी उद्योग 

नेपालमा हाल करिब ७२ वटा औषधी उद्योगहरु संचालनमा छन् । अरु करिब ३२ वटा उद्योगहरु निर्माणका क्रममा छन् । विभीन्न अन्तराष्ट्रीय मापदण्डको पालना गर्दै गुणस्तरीय औषधी सुलभ मुल्यमा उपलब्ध गराउन नेपाली औषधी उत्पादकहरु सक्षम रहेका छन् । पछिल्ला वर्षमा नेपाली औषधीहरु निर्यातको शुरुवात भएको छ । वदेशमा औषधी उत्पादनका जनशक्ती उपलब्ध छन् भने प्रविधि पनि उपलब्ध छन् । स्थापीत उद्योगहरु करिब ५०% औषधीमा आत्मनिर्भरता तर्फ ?दीपक प्रसाद दाहालसदस्यः औषधि परामर्श परिषद भन्दाकम क्षमतामा संचालीत छन् । अहिलेको अवस्थामा देशलाई आवश्यक ७५% भन्दा बढी औषधी दिन सक्षम छन् । नेपाल औषधी बजारमा भ्याक्सीन बाहेक भारतीय उत्पादन ५०% नेपाली ४५% र अन्यको ५% बजार हिस्सा रहेको छ । सरकारले सितैमा बाड्ने करिब ९०% र सम्पूर्ण औषधिको ७५% औषधी उत्पादन गर्न सक्ने अवस्था विद्यमान रहेको भएपनि सरकारी उदासिनताले बजारको ४५% हिस्सामा खुम्चिनु परेको छ । औषधी व्यवस्था विभागको सहयोग र अभिभावकत्वमा हुर्केको नेपाली औषधी उद्योगहरु, खासगरि औषधी व्यवस्था विभागको २०७२ पछिको कृयाकलापकले स्वदेशी उद्योगहरुलाई नराम्रो सँग खुम्चीन बाध्य पारीएको छ । औषधी उत्पादन र नियन्त्रणको प्रष्ट कानुन र नियमावली हुँदा हुँदै विभागले अनावश्यक कार्यविधिहरु लागु गरि औषधी उद्योगलाई नयाँ औषधीको उत्पादन अनुज्ञापत्र जस्ता आवश्यक कागजात र अनुमती लिन बर्षांै लगाइने गरिएको छ । जनशक्तीको अभावको वाहानामा हप्ता दिनमा हुने काम ६ महिना सम्म पनि नहुने गरेको छ । औषधी व्यवस्था विभागका नेतृत्वनै औषधीको गुणस्तर मुल्यको बारेमा भ्रम छर्ने, नेपाल सरकारले लागु गरेको निती विपरित काम गर्ने, कार्य सम्पादन करार सम्झौता अनुसार कार्य सम्पादन नगर्ने जस्ता कार्यले स्वदेशी औषधी उत्पादनहरु अप्थ्यारोमा परेका छन् । यस कुरालाई समाधान गर्न प्रधानमन्त्रीको सचिवालयले स्वास्थ्य मन्त्रालयलाई औषधी व्यवस्था विभागको पुनसंरचनाको लागी समेत लेखेर पठाएको छ । भारतिय उत्पादनहरु नेपाली औषधीहरुको मुख्य प्रतिस्पर्धी हो । भारतीय औषधी उद्योगहरु भारत सरकारको संरक्षण र अनुदानमा चल्ने गरेका छन् । भारतमा सरकारी लगानीमा दर्जनौं औषधीको अनुसन्धान तथा विकास गर्ने संस्थाहरु छन्, जसले प्रविधिको विकास गरि औषधि उद्योगलाई प्रविधि हस्तान्तरण गर्छन् । नेपालमा औषधी ऐन २०३५ ले औषधी अनुसन्धान शालाको स्थापनाको व्यवस्था गरे पनि हाल औषधी व्यवस्था विभागमा औषधी प्रयोगशालाको रुपमा खुम्च्याइएको छ । भारत सरकारले ३५ वटा शिर्षक अन्तर्गत औषधी उद्योगलाई अनुदान दिने गरेको छ भने हालै भारु १५० अर्वको अनुदान प्याकेज राजपत्रमा प्रकासीत गरी लागु गरेको छ । भारत परिमाणको आधारमा औषधि उत्पादन गर्ने विश्वको तेस्रो ठुलो मुलुक हो भने मुल्यको आधारमा चौधौं ठुलो मुलुक हो । संसारमा सबै भन्दा सस्तो मुल्यमा औषधी उत्पादन गर्ने देश हो – भारत । भारतले औषधी उत्पादनमा १% ले उत्पादकत्व बढायो भने नेपाललाई एक वर्ष पुग्ने औषधी उत्पादन हुन्छ । त्यसैले औषधीमा आत्मनिर्भर हुनको लागी सरकारले आधारभुत संरक्षण दिनु पर्दछ । सरकारको निती तथा कार्यक्रममा औषधीमा आत्मनिर्भर बन्ने कुरा आएपनि कार्यान्वयन हुन सकेको छैन । केही वर्ष अगाडी सम्म औषधीमा भारत निर्भर बंगलादेश अहिले औषधीमा आत्मनिर्भर भइ विश्वको १२० देश भन्दा बढी देशमा औषधी निर्यात गर्ने देश भएको छ । बंगलादेशले स्वदेशी दुइ वा दुइ भन्दा बढी उत्पादकले उत्पादन गर्ने औषधीको कच्चापदार्थ मात्र आयात गर्ने तयारी औषधी आयात गर्न नदिने निती लिएको कारण आज औषधीको विश्वबजारमा बंगलादेश उपस्थीत हुन सकेको छ । नेपालले पनि यस्तै निती अवलम्बन गर्नको लागी माननीय गगन थापा स्वास्थ्य मन्त्री भएको बेला २०७३ सालमा औषधी व्यवस्था विभागका महानिर्देशकको अध्यक्षतामा समिति बनाई प्रतिवेदन तयार गराइएको थियो जसले २०७४ साल आसाढ मसान्त पछि नेपालमा प्रसस्त उत्पादन हुने ३० प्रकारका औषधीको कच्चापर्दाथ मात्र आयात गर्न दिने प्रतिवेदन हाल सम्म लागु गर्न सकेको छैन । त्यस्तै औषधी व्यवस्था विभागको २०६१–९–२० को सूचनाको बुँदा अनुुसार निरिक्षण गरी दर्ता गर्ने प्रयोजनका लागी आधुनिक औषधी उद्योगको आवेदन अब नलिने र निरिक्षण गर्न पनि नजाने निर्णय विपरीत हरेक वर्ष दर्जनौं विदेशी उद्योगको निरिक्षण गरी औषधी दर्ता गरिदैं आएको छ । सरकारले २०५१ सालको औषधी नितीमा १० वर्ष भित्र अत्यावश्यक औषधीको उत्पादनमा ८०% आत्मनिर्भर हुने निती लिए अनुसार स्वदेशी उत्पादकले उत्पादन क्षमता बढाए पनि सरकारले संरक्षण नदिंदा आजसम्म लागु हुन सकेको छैन । २०७१ सालको स्वास्थ्य निती २०७५÷७६ को बजेत बक्तब्यमा औषधीमा आत्मनिर्भर बन्ने कुरा राखीए पनि कार्यान्वयन हुन सकेको छैन । त्यसो त औषधी ऐन २०३५ को परिच्छेद दुइमा औषधी परामर्श परिषद र औषधी सल्लाहकार समितिको व्यवस्था राखिएको छ । औषधी परामार्श परिषद र औषधी सल्लाहकार समिति गठन नियमावली २०३७ ले परिषदको काम, कर्तब्य र अधिकारको बुँदा १ मा औषधीमा देशलाई स्वावलम्बी बनाउने मुख्य उद्धेश्यलाई ध्यानमा राखी औषधी सम्बन्धी सैधान्तिक तथा प्रशासनिक विषयमा नेपाल सरकारलाई परामर्श दिनु परिषदको कर्तव्य हुनेछ भनिएपनि विगत ४१ वर्षमा परिषदको जम्मा १७ वटा बैठक मात्र बसेको छ र पछिल्ला बैठकका निर्णयहरु कार्यान्वयन हुन सकेको छैन ।

 img
Multisectoral Impact of Covid-19 Pandemic

Covid-19 originated from Wuhan China during Dec 2019 caused havoc across the world urging WHO to declare it as Pandemic. The pandemic impacted on multisectoral fronts with multifaceted effects costing several lives and shattering hopes. Global economy was impaired. According to the Central Bureau of Statistics (March 2021) – Nepal’s economy was in negative growth -15.4%. Remittances from Nepali workers abroad defied expectations and rose to NRs 729.02 billion (USD 6.23 billion) with 16.5% increase compared to the same period last year. 

 

Loss of lives and psychosocial impact: 

The Covid-19 pandemic costed several lives mostly elderly and those suffering from chronic diseases specially respiratory diseases. The latest figure till 10th April 2022 total infections worldwide is 477,445,135 with fatality of 6,110,521 and in Nepal 1,118,717 and fatality of 11,951. It is also assumed that many persons lost the battle due to fear and psychosis of Covid 19. The family members of those demised also lost their lives due to shock or reeling under psychological setback. The healthcare safety measures restricted the free mobility of people keeping them apart from loved ones. Such isolation and seggregation among loved ones further added the psychological impact. HIGHLIGHTS 

 Health 

There are concerns around low rates of routine immunization, low testing rates, and lack of access to medicines, driven by a lack of low income, travel restrictions, unavailability of health workers or fear of transmission of COVID-19 while seeking services. The low number of tests and high (almost 1 in 5) rate of infection caused fear of further community transmission of COVID-19 and preventive measures were still needed to control further spread of the disease. The maternal mortality rate, complications increased due to lack of transportation and access to healthcare facilities. National Innovation Center led by Mahabir Pun immensely contributed to contain Covid-19 by producing Personal Protection Equipment – PPE for healthcare professionals, fixed the breakdown of biomedical equipment/devices like ventilators etc, rendered preventive maintenance & servicing to ensure uninterrupted services during critical period at no cost. Nevertheless, the hospitals have been well equipped and prepared to combat such pandemic or outbreak of critical and life threatening diseases. Many survivors and sufferers of Covid-19 are living with long Covid-19, which adversely affecting their daily functional activities. Some became victim of black fungus rendering loss of eye sight. Pharmaceutical industry, Oxygen plant played vital role in their part to produce and supply oxygen and medicines needed for the patients. Nepal is heavily dependent on India for medicines, the unfortunate part during Covid-19 pandemic was India imposed restrictions for export of crucial medicines like Paracetamol, Steroids, Remdesivir, Tocilizumab, Liposomal Amphotericin B etc. Paucity of supply of those crucial medicines created panic among people. At last Nepalese company National Health Care Pvt. Ltd became successful to produce and supply. Remdesivir. Some gaps in demand was fulfilled through the supply received from China and Bangladesh. The great lesson learned from Covid-19 pandemic is to encourage and enhance national industry to expnad the product portfolio, scale up technological and innovative capabilities to meet the therapeutic demand during such critical condition. Essential and critical care medicines’ manufacture and supply: National pharma industry accepting the fierce challenge to combat the Covid pandemic and save people’s life, manufactured all essential medicines incessantly by applying and following all public health safety measures during the lockdown and restrictions. The national pharma industry strived day and night to fulfill the dire need of highly needed and critical care medicines like Paracetamol, Corticosteroids, Remdecivir, Azithromycin, IV fluid, etc. Hand Sanitizer and alike. 

Nepalese Pharma industry forged ahead to supply the medicines across the country, when in fact the whole world was under lockdown, there was no eatery on the highway or any where in transit to the destination. Transportation and shipment was pretty expensive. The national pharma industry and enterpreneurs deserve great appreciation for their immense dedication without longing for profit and extra benefit.The role of pharmaceutcal traders, engaged in import and distribution of essential and critical & life saving medicines was also important in supply of essential and critical care & life saving medicines, when in fact govt. of India imposed restriction on export of such medicines. The enterpreneurs explored far & wide and made it available. Temperature controlled medicines (cold/cool chain medicines) were transported by cold chain/AC van, as the aviation was restricted. The fast action of Nepal Health Research Council and Medicine Regulatory body for facilitation is applaudible. The vehicle drivers exhibited tremendous courage and firm determination to the mission to cater medicine irrespective of uncertainties of food and shelter. Their role is equally invocable. Covid pandemic taught great lession that the dependency on import of essential commodities like medicines directly impacts people’s livelihoods and well-being. Our initiative and thrust must be to improve health and health security by “Strengthening Pharmaceutical Sustenence”. 

 Amidst Covid pandemic, United Nations of late has backed Medicines Patent Pool- MPP program with aim to increase access to, and facilitate the development of, life-saving medicines for low and middle income countries through an innovative approach to voluntary licensing and patent pooling. Such initiative ensure rapid access to effective treatments, health technologies in home country without relying on import. The avenue of MPP is extensive encompassing HIV, Hepatitis C and Tuberculosis including Covid-19 treatments and pandemic preparedness. As many as 16 low and middle-income countires are now included in MPP involving almost 60 manufacturing sites across the globe. Nepalese Pharmaceutical Industry must vouch for such golden opportunities offered through global organization like UN. It may not be feasible at the mere initiative of the pharma industry alone. The government and international development partners as well as stakeholders must come forward to shoulder the national industry. The nation as a whole should revamp capability and grab full advantage of MPP for “Strengthening Pharmaceutical Sustenence”. 

 Food Security, Livelihoods, Nutrition and Social Protection Programmes


 Restrictions on the movement of people and commodities have severely limited people’s ability to earn, access necessities and commodities, and enjoy food security. This has affected the most vulnerables. Continuous lockdowns restricting movement and therefore the ability to earn livelihoods and access essentials, and the limited provision and accessibility of social protection schemes are contributing factors to the food insecurity status in Nepal. Hats off to Philanthropic and Non-governmental organizations, which came forward to distribute food and medical supplies as well as hyegiene and sanitation kits to the underpriviledged. Though it was not adequate or sufficient to meet the need during entire Covid-19 period. Social organizations also contributed to provide Oxygen cylinders, Oxygen concentrators and sanitation items like hand wash system etc. 

 Education 


Most children were staying at home and/or schools remain closed during COVID-19 lockdowns. The ability of caregivers to support learning at home, and the accessibility of learning tools – including online, virtual, and physical – varies, most significantly affecting vulnerable rural households. The closure of educational institutions has led to the postponement of all national level examinations and formal education has largely discontinued at schools. Learning and skills development of students has been affected, impacting student assessment, drop-out rates, and advancement into upper grades without the development of the requisite skills.

 COVID-19 Risk Communication

 Majority of population have a level of knowledge of COVID-19 and are aware of preventive measures, but a gap between knowledge and practice in relation to limiting the spread of COVID-19 is evident. 

Digital technology: The Covid-19 pandemic provided opportunity to surge digital technology. The physically apart people remained in connection through digital tech system. The digital communication became preferred option to hold meeting remotely and digital sign obtained official recognition. Digital marketing also got ground for promotion of products and services including pharmaceuticals. Online marketing, online supplies were also practiced extensively.

Digital technology and devices like Tele-health, Telemedicine, Artifical intelligence are widely used by health sector to cater healthcare services remotely. Covid pandemic impelled people to hold formal meeting, seminars, conferences as well as training etc through digital technology. Zoom, MS Team, Google meet, messenger, viber group call, skype etc are some leading remote digital meeting modality being used. The digital technology has also been extensively used remotely by psychologists, clericks, priests for psychosocial counselling, preaching and even to perform rituals and even last rituals of deceased.

Aviation, Tourism and Hospitality sector:The entire sector was almost paralysed. Limited operation of aviation caused paucity of essential, life saving and critical care medicines. Hospitality, Travel and tourism sector was worst affected.

Agriculture sector: Agri production had difficulty for access to market and reach out to consumer. The consumer on the other end were deprived of supply of agri products and compelled to pay high price.

Manufacturing sector: Non-essential sector was worse affected, though Essential sector manufacturing was relaxed to run; however, public health safety factor for work force became the hitches. Due to closure of academic institutions the paper industry faced lack of paper demand in the market.

Environmental sector: The restriction on human activity during Covid pandemic offered huge respite to the environment, the silver lining on the cloud is the polution level sank nearly to the rock bottom.

Public health safety sector: The public health safety and sanitation sector leaped forward due to huge demand for public health safety and sanitation kits like hand sanitizer, face mask/cover, face shield, IR thermometer, Pulse/Oxymeter, Personal protection equipment-PPE etc. The Covid-19 pandemic preached good lesson to human folk to practice health hyegiene and sanitation in day to day life and remain healthy.

Remarkable achievement in Vaccine development:


The most remarkable achievement is development of vaccines for emergency use against Covid in short span of time. Accolade to the scientists for their outstanding performance. Though the big question mark is on fair and justifiable distributioin of vaccines across the globe. Massive consumption and holding of vaccine done by developed nations is not justifiable and fair. The response to the impact of COVID-19 require policy and programming options at multiple levels and by multiple stakeholders – national and local government, communities, development partners, local and international organizations.


 

APPON Members
Contact Us
Connect with APPON
APPON has more than 70+ pharmaceutical companies associated as its members spread all across the country.
APPON Head Office
Teku, Kathmandu Nepal
Bagmati Chamber, 4th floor Room no. 401
G.P.O Box No. 23528
+977-1-4100024, 4231871
appon123@gmail.com